{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:52:36Z","timestamp":1775227956088,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["1217MFDS308"],"award-info":[{"award-number":["1217MFDS308"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The immunization schedule for the Japanese encephalitis (JE) vaccine in Korea is a two-dose primary series at 12\u201324 months of age, followed by booster doses 12 months after the second dose and at the ages of 6 and 12 years. Although the number of JE cases has markedly decreased after the universal vaccination program, JE predominantly occurs in adults. The aim of this study was to assess the age-specific prevalence of the JE-neutralizing antibody (NTAb) among adolescents and adults in Korea. A total of 1603 specimens were collected from a healthy Korean population above 15 years old in five provinces. The JE-NTAb titers were measured with the pseudotyped virus assay and considered to be positive at \u2265 1:50. The seropositivity of JE-NTAb was the highest in the 15\u201329 years category (&gt;95%) and gradually began to decrease in the age group of 30\u201344 years (89.42%). The lowest and second lowest JE-NTAb seropositive rates were observed among those aged 70 years or older (59.77%) and those aged 55\u201359 years (75.24%), respectively. Subjects from Seoul exhibited the highest JE-NTAb titer in all age groups compared to other provinces. In conclusion, the JE-NTAb seropositive rates and titers have maintained appropriate levels in the general Korean population. We propose that adult immunization and boosters at 12 years of age against JE are not strongly recommended in Korea.<\/jats:p>","DOI":"10.3390\/vaccines8020328","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T10:43:58Z","timestamp":1592563438000},"page":"328","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Seroprevalence of Neutralizing Antibodies against Japanese Encephalitis Virus among Adolescents and Adults in Korea: A Prospective Multicenter Study"],"prefix":"10.3390","volume":"8","author":[{"given":"Byung Ok","family":"Kwak","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hallym University Kangnam Sacred Heart Hospital, Seoul 07441, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Se","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Inha University School of Medicine, Incheon 22332, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jin","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Inha University School of Medicine, Incheon 22332, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Hyun","family":"Nahm","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Inha University School of Medicine, Incheon 22332, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8376-0133","authenticated-orcid":false,"given":"Woori","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Inha University School of Medicine, Incheon 22332, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2879-7870","authenticated-orcid":false,"given":"Young","family":"Uh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-6875","authenticated-orcid":false,"given":"Yong Gon","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chonbuk National University Medical School and Hospital, Jeonju 54907, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chungnam National University Hospital, Daejeon 35015, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-0168","authenticated-orcid":false,"given":"Myungshin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary\u2019s Hospital, Seoul 06591, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9883-0229","authenticated-orcid":false,"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Inha University School of Medicine, Incheon 22332, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"ref_1","unstructured":"Plotkin, S.A., Orentein, W.A., Offit, P.A., and Edwards, K.M. (2018). Japanese encephalitis vaccines. Plotkin\u2019s Vaccines, Elsevier. [7th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis-within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_3","unstructured":"Salisbury, D., Ramsay, M., and Moakes, K. (2006). Japanese encephalitis. Immunisation Against Infectious Disease, Crown. [3rd ed.]."},{"key":"ref_4","first-page":"161","article-title":"Japanese encephalitis in the USSR","volume":"30","author":"Grascenkov","year":"1964","journal-title":"Bull. World Health Org."},{"key":"ref_5","unstructured":"Kim, J.H. (2018). Japanese encephalitis vaccines. Immunization Guideline, The Korean Pediatric Society. [9th ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lee, E.J., Cha, G.W., Ju, Y.R., Han, M.G., Lee, W.J., and Jeong, Y.E. (2016). Prevalence of neutralizing antibodies to Japanese encephalitis virus among high-risk age groups in South Korea, 2010. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151227"},{"key":"ref_7","first-page":"17","article-title":"Japanese encephalitis immunization in South Korea: Past, present, and future","volume":"6","author":"Sohn","year":"2000","journal-title":"Emerg. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3201\/eid2210.160288","article-title":"Reemergence of Japanese encephalitis in South Korea, 2010\u20132015","volume":"22","author":"Sunwoo","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7883\/yoken.JJID.2008.333","article-title":"Vaccine Preventable Diseases Surveillance Program of Japan. Japanese encephalitis: Surveillance and elimination effort in Japan from 1982 to 2004","volume":"61","author":"Arai","year":"2008","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hsu, L.C., Chen, Y.J., Hsu, F.K., Huang, J.H., Chang, C.M., Chou, P., Lin, I.F., and Chang, F.Y. (2014). The incidence of Japanese encephalitis in Taiwan\u2014A population-based study. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003030"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1067\/mic.2003.73","article-title":"Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: A comparative study between urban city and country townships","volume":"31","author":"Tseng","year":"2003","journal-title":"Am. J. Infect. Control."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.14776\/kjpid.2013.20.3.131","article-title":"Immunogenicity and protective effectiveness of Japanese encephalitis vaccine: A prospective multicenter cohort study","volume":"20","author":"Kim","year":"2013","journal-title":"Korean. J. Pediatr. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yun, K.W., Lee, H.J., Kang, J.H., Eun, B.W., Kim, Y.J., Kim, K.H., Kim, N.H., Hong, Y.J., Kim, D.H., and Kim, H.M. (2015). Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC\u00ae) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: A phase III, multicenter, double-blinded, randomized trial. BMC Infect. Dis., 8.","DOI":"10.1186\/s12879-014-0744-4"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijid.2017.11.023","article-title":"Systematic review of seroepidemiological studies on Japanese encephalitis in the Republic of Korea","volume":"67","author":"Choe","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12275-014-3529-y","article-title":"Comparison of JEV neutralization assay using pseudotyped JEV with the conventional plaque-reduction neutralization test","volume":"52","author":"Lee","year":"2014","journal-title":"J. Microbiol."},{"key":"ref_16","first-page":"13","article-title":"Status and significance of inapparent infection with virus of Japanese B encephalitis in Korean and Okinawa in 1946","volume":"51","author":"Deuel","year":"1950","journal-title":"Am. J. Hyg."},{"key":"ref_17","first-page":"83","article-title":"Recent epidemiological features of Japanese encephalitis in the Republic of Korea","volume":"6","author":"Kim","year":"1974","journal-title":"Korean J. Infect. Dis."},{"key":"ref_18","first-page":"21","article-title":"The distribution of hemagglutination inhibition antibody for Japanese encephalitis in residents of Seoul areas","volume":"19","author":"Kim","year":"1976","journal-title":"Choeshin Ui-hak"},{"key":"ref_19","first-page":"75","article-title":"Serological study on Japanese encephalitis in Koreans and fowls, 1975","volume":"8","author":"Lee","year":"1976","journal-title":"Korean J. Infect. Dis."},{"key":"ref_20","first-page":"51","article-title":"The distribution of hemagglutination inhibition antibodies for Japanese encephalitis virus against the Koreas 1976","volume":"12","author":"Lee","year":"1977","journal-title":"J. Korean Soc. Microbiol."},{"key":"ref_21","unstructured":"Lee, C.H., Lee, Y.T., and Ko, K.K. (1979). The distribution of hemagglutination inhibition antibodies for Japanese encephalitis virus in Korea (1977, 1978). Choeshin Ui-hak, 113\u2013119."},{"key":"ref_22","first-page":"65","article-title":"The distribution of hemagglutination inhibition antibodies for Japanese encephalitis virus in Koreans 1979","volume":"10","author":"Lee","year":"1980","journal-title":"Korean J. Virol."},{"key":"ref_23","first-page":"1","article-title":"A hemagglutination inhibition antibody test for Japanese encephalitis virus among the Koreans, 1984\u20131985","volume":"15","author":"Lee","year":"1985","journal-title":"Korean J. Virol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/2\/328\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:41:00Z","timestamp":1760175660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/2\/328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["vaccines8020328"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8020328","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]}}}